These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3416086)

  • 1. [Pharmacokinetics in phase IV studies for the preview of a therapeutic protocol].
    Favre R; Charbit M; Rinaldi Y; Iliadis A; Cano JP; Carcassonne Y
    Bull Cancer; 1988; 75(6):541-50. PubMed ID: 3416086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of a new interactive software monitoring a controlled-flow infusion pump for cisplatin dosage regimen adjustment].
    Cupissol D; Brès J; Gestin-Boyer C; Nouguier-Soulé J; Vian L; Tep A; Nouguier J
    Bull Cancer; 1996 Aug; 83(8):664-76. PubMed ID: 8869047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermic isolated regional perfusion with CDDP for bone and soft-tissue sarcoma of the lower limb: pharmacokinetics, thermal dose, toxicity, and feasibility.
    Abe S; Tokizaki T; Miki Y; Tateishi A; Ogawa K; Nakano H; Matsushita T
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):55-62. PubMed ID: 15791455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 2- and 3-compartment models for the Bayesian estimation of methotrexate pharmacokinetics.
    Sabot C; Debord J; Roullet B; Marquet P; Merle L; Lachatre G
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):164-9. PubMed ID: 7599915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy.
    Panteix G; Beaujard A; Garbit F; Chaduiron-Faye C; Guillaumont M; Gilly F; Baltassat P; Bressolle F
    Anticancer Res; 2002; 22(2B):1329-36. PubMed ID: 12168946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
    Monjanel-Mouterde S; Lafforgue P; Blanc A; Catalin J; Aquaviva PC; Durand A
    J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Animal pharmacokinetics in the quantitative estimation of clinical pharmacokinetics of antitumor agents].
    Hecquet B
    Bull Cancer; 1988; 75(4):385-9. PubMed ID: 3382772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
    Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
    Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of cisplatin in adult cancer patients.
    de Jongh FE; Gallo JM; Shen M; Verweij J; Sparreboom A
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):105-12. PubMed ID: 15127229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
    Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
    Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of cisplatin after 120-h infusion: application to routine adaptive control with feedback.
    Monjanel-Mouterde S; Ciccolini J; Bagarry D; Zonta-David M; Duffaud F; Favre R; Durand A
    J Clin Pharm Ther; 2003 Apr; 28(2):109-16. PubMed ID: 12713607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and individual dose adjustment of carboplatin].
    Chatelut E; Canal P; Bugat R
    Bull Cancer; 2000 Aug; 87 Spec No():17-23. PubMed ID: 11082718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic analysis of intra-peritoneal administration of cisplatin].
    Terashima M; Ikeda K; Takagane A; Sasaki N; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Nakaya T; Oyama K; Saito K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1859-62. PubMed ID: 9382551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of computers to pharmacokinetics, Bayesian approach and population pharmacokinetics].
    Hecquet B
    Bull Cancer; 1995 Dec; 82 Suppl 5():607s-611s. PubMed ID: 8680074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia.
    Plard C; Bressolle F; Fakhoury M; Zhang D; Yacouben K; Rieutord A; Jacqz-Aigrain E
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):609-20. PubMed ID: 17195068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites.
    Verschraagen M; Boven E; Ruijter R; van der Born K; Berkhof J; Hausheer FH; van der Vijgh WJ
    Clin Pharmacol Ther; 2003 Aug; 74(2):157-69. PubMed ID: 12891226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.